ClinicalTrials.gg
Not yet recruitingNCT07650734Updated Jun 16, 2026

Posture, Tongue Position and Pronunciation

An interventional study of speech therapy treatment and speech therapy treatment and strengthening exercise in Speech Dysfunction, sponsored by University of Haifa. Not yet recruiting. Open to participants aged 6 Years to 15 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-16.

Sponsored by University of Haifa · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
6 Years to 15 Years
Sex
All
01

Study summary

Background: The main speech organ that affects the pronunciation of the various vowels is the tongue. The relationships between posture and voice, and between the position of the tongue at rest and posture, have been proven, but the relationship between pronunciation and posture has not yet been proven. The rationale for examining this relationship is that the imbalance and differing loads in poor neck and head posture cause different muscular arrangements of the muscles that support the jaw, tongue, and neck, which will thus affect pronunciation.

Objectives: To examine the relationship between posture, tongue position, and the correct pronunciation in subjects with and without pronunciation disorders. In addition, to examine the effect of a muscle strengthening program on these characteristics.

Methods: The study will include two parts. The first part will be a cross-sectional study using a questionnaire to examine speech therapists' perceptions of the relationship and importance of posture and pronunciation. The second part will include a prospective interventional clinical study to examine the relationship between tongue position at rest and pronunciation, posture, and muscle strength. In addition, the effect of adding muscle-strengthening training to conventional pronunciation therapy on the process of acquiring correct pronunciation will be examined.

Read the detailed description

This study will examine the relationship between posture, tongue position, and correct pronunciation in subjects with and without pronunciation disorders. In addition, we will examine the effect of a muscle-strengthening program on these characteristics.

The first part will include an online questionnaire to examine speech therapists' perceptions of the relationship and importance of posture in speech therapy treatment.

The second part will include a prospective interventional clinical study with participants with and without pronunciation disorders. The evaluation measures will include: assessment of the pronunciation by a speech therapist, assessment of posture (mobile app), assessment of tongue position at rest and during pronunciation (observation and ultrasound), measurement of neck and upper limb muscle strength (manual dynamometer), tongue strength (digital measuring spoon), jaw closing muscle strength (Byte), breathing, and swallowing (observation).

The study group with pronunciation disorder will be divided into 2 groups: the intervention group will receive an exercise program to strengthen the neck and upper-limb muscles in addition to regular speech therapy treatments. The control group will receive the regular speech therapy treatments. The evaluation measures will be reviewed again at the end of the treatment series (up to 10 treatments).

02

Conditions studied

  • Speech Dysfunction

Browse trials for

Keywords

  • pronunciation
  • posture
  • muscles
  • strength
  • tongue
03

In context

Speech

205 studies on the registry are indexed under Speech; 80 are open to participants now.

This study's planned enrollment of 80 is above the median of 52 across 141 interventional studies indexed under Speech.

Browse Speech studies →

Lead sponsor

University of Haifa is the lead sponsor of 105 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 15 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • People with normal hearing
  • with and without pronunciation disorders

Exclusion criteria

Exclusion Criteria:

  • Children and teenagers who study in special education settings,
  • children and teenagers with phonological disorders at the prosodic or segmental level,
  • children and teenagers whose parents are under the impression that they do not hear well.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    excercise

    will receive speech therapy treatment and, in addition, exercises for the neck and upper extremities.

    Other: speech therapy treatment and strengthening exercise

  • Active comparator
    Control

    will receive regular speech therapy treatment according to their disorder

    Other: speech therapy treatment

  • No intervention
    healthy control

    healthy control for baseline comparison, no treatment

Interventions

  • Otherspeech therapy treatment

    regular treatment to enhance good pronunciation

  • Otherspeech therapy treatment and strengthening exercise

    speech therapy treatment and strengthening exercise

06

What researchers measure

Primary outcomes

  1. Treatment success

    number of treatments until good pronunciation is achieved

    Time frame: at completion of intervention - up to 10 weeks

Secondary outcomes

  1. neck muscle strength

    flexion and side flexion neck muscle strength via hand held dynamometer. Recorded in kilograms of force (kgf)

    Time frame: baseline, at completion of intervention - - up to 10 weeks

  2. Tongue strength

    Tongue strength will be assessed using a digital measuring spoon. Measurements will be recorded in g/cm2

    Time frame: base line, at completion of intervention - - up to 10 weeks

  3. Jaw closing strength

    jaw closing strength via Byte device

    Time frame: base line, at completion of intervention- - up to 10 weeks

  4. Tongue thickness

    Tongue thickness will be measured using ultrasonography. Measurements will be recorded in millimeters (cm).

    Time frame: base line, at completion of intervention- - up to 10 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jul 2028, 24 months later.

Of 85 non-industry interventional studies with no phase under Speech, half reached primary completion within 45 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 65. This study's planned 24 months is below that.

Counting every sponsor, half of 90 studies reached it within 45 months; a quarter within 15 and three quarters within 65.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2026
First posted
Jun 16, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Jul 1, 2028
CompletionEst.
Jul 1, 2028
Last update
Jun 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 16, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07650734
Responsible party
Gali Dar (Prof., University of Haifa) — Principal investigator
First posted
Jun 16, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Jul 1, 2028 (estimated)
Completion
Jul 1, 2028 (estimated)
Last update
Jun 16, 2026

Study contacts

Gali Dar, PhD
Contact
gdar@univ.haifa.ac.il
+972505662054

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion